Schizophrenia, as a mental disorder, has been well documented with both structural and functional magnetic resonance imaging. The developing field of connectomics has attracted much attention as it allows researchers to take advantage of powerful tools of network analysis in order to study structural and functional connectivity abnormalities in schizophrenia. Many methods have been proposed to identify biomarkers in schizophrenia, focusing mainly on improving the classification performance or performing statistical comparisons between groups. However, the stability of biomarkers selection has been for long overlooked in the connectomics field. In this study, we follow a machine learning approach where the identification of biomarkers is addressed as a feature selection problem for a classification task. We perform a recursive feature elimination and support vector machines (RFE-SVM) approach to identify the most meaningful biomarkers from the structural, functional, and multi-modal connectomes of healthy controls and patients. Furthermore, the stability of the retrieved biomarkers is assessed across different subsamplings of the dataset, allowing us to identify the affected core of the pathology. Further analysis of the connectivity strength of the affected core quantified with the generalized fractional anisotropy (gFA) and apparent diffusion coefficient (ADC) reveal a significant alteration in patients. Considering our technique altogether demonstrates a principled way to achieve both accurate and stable biomarkers while highlighting the importance of multi-modal approaches to brain pathology as they tend to reveal complementary information.
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Schizophrenia (SZ) is a severe psychiatric disorder characterized by hallucinations and delusions, as well as impairments in memory, attention, executive and other high-order cognitive dysfunctions (1) . The development of magnetic resonance imaging (MRI) has offered an effective way to examine the anatomy of the brain and has motivated numerous scientists to explore the underlying neuropathology of SZ. Over the past few years, advances in high-field structural and functional neuroimaging have made it possible to map the macroscopic neural wiring system of the human brain (2, 3) . This framework allows us to combine a graph theoretical approach with functional and/or diffusion MRI to investigate the brain network alterations occurring in SZ (4) (5) (6) . Studies from the graph theory perspective have shown alterations of both structural and functional brain topology in SZ characterized by a less efficient network organization and the limited capacity of functional integration. Further research using diffusion spectrum imaging reported the brain areas responsible for the loss of network integration and segregation properties (5, 7, 8) . However, such findings were identified using conventional univariate strategies performing a separate statistical test at each edge of the connectome under scrutiny, thereby requiring excessively stringent corrections for multiple comparisons. On the other hand, multivariate methods are promising, although they require specialized approaches when the number of parameters dominates the observations (9) . In this study, we adopt a machine learning approach that aims at discovering the most relevant set of biomarkers for discriminating subjects groups and thus quantitatively describing the group differences, both in terms of classification accuracy and stability of selected features.
A Machine learning and automatic biomarker selection
The identification of regions or connections of interest associated with a neural disorder is referred to as biomarker discovery. The identification of such biomarkers in schizophrenia could lead to clinically useful tools for establishing both diagnosis and prognosis. From a machine learning perspective, the choice of biomarkers can be addressed as a feature selection problem, aiming to find a subset of relevant features allowing us to differentiate patients from control subjects accurately.
In this work, we perform an automatic feature selection procedure in order to identify biomarkers that are relevant for the diagnosis of schizophrenia from brain connectivity data. In this context, biomarkers, therefore, correspond to structural or functional links between neural Regions of Interest (ROIs).
A key challenge in feature selection lies in the fact that diverse feature selection methods might result in different sets of retrieved features. Even when using the same technique, it may produce different results when applied to different splittings of the data. When the dimensionality of the input data is large and exceeds the number of training examples, the complexity grows by several orders of magnitude (10, 11) . As a consequence, when two subsets of features are compared the decision of which should be preferred involves uncertainty (12) . These issues underline the need to integrate the stability in the feature selection process so that the method can retrieve consistent features across random subsamplings of the dataset. This is especially true in a biomedical context where many authors have focused on improving the classification performance in several mental disorders such as schizophrenia (13) , Alzheimer (14) , depression (15) . Even though the stability of biomarker selection has been studied mainly in genomics and proteomics (12? ), the stability of feature selection has been overlooked in the connectomics community. Therefore, we propose a general framework for stability analysis of selected features, thereby enabling the robust identification of impaired connections in the connectome of schizophrenic patients. The proposed approach is extendable to other brain disorders as well.
In the present work, we use Support Vector Machines (SVM) as a classifier (10). This is a supervised machine learning method that aims to classify data points by maximizing the margin between classes in a high-dimensional space. This classifier offers state of the art classification performances on a wide range of applications and is particularly appropriate for high-dimensional problems with few examples. The SVM classifier has been integrated into an embedded feature selection approach (? ). The so-called Recursive Feature Elimination with Support Vector Machine (RFE-SVM) technique was first introduced to perform gene selection for cancer diagnosis on microarray data (16) . More recently, it has also been used on human brain networks to identify differences in structural connectivity related to gender (? ). This method trains an SVM classifier removing the less important features and iteratively re-estimating the classifier with the remaining features until reaching the desired number of them. Accordingly, we adopt the RFE-SVM approach to automatically select brain connections that lead to the best discrimination between patients and controls, and consequently to highlight brain regions that are responsible for the disease. The aim of the present work is threefold: First, we investigate the effect of structural, functional, and multi-modal (struc-tural+functional) connectome with different resolutions in the classification performance of schizophrenia. Second, we perform a careful feature selection procedure across modalities in order to assess the robustness of the selected features providing the best trade-off between high accuracy and stability. Finally, the analysis of retrieved biomarkers allows us to identify a distributed set of brain regions engaged in the discrimination of patients and control subjects. This paper is organized as follows: Section 2 introduces the properties of the dataset, the procedure for connectomes estimation as well as the general protocol we used in biomarkers identification. In section 3, we present the results on stability, classification performances, and identification of brain areas indicative of the pathology. Finally, in section 4, we lead a discussion on our findings and conclusions.
Materials and methods A Subjects
For this study, two age-balanced groups were considered. The cohort consisted of a schizophrenic group of 37 subjects with a mean age of 40.9 ± 9.4 years and a control group of 37 healthy subjects with a mean age of 32.3 ± 7.6 years. The patients in the schizophrenic group were recruited from the psychiatric clinic at the Lausanne University Hospital. They met DSM-IV criteria for schizophrenic and schizoaffective disorders (American psychiatry association, 2000 ref). We obtained written consent from all the subjects following the institutional guidelines approved by the Ethics Committee of Clinical Research of the Faculty of Biology and Medicine, University of Lausanne, Switzerland.
B Brain network estimation Magnetic resonance imaging
All subjects were scanned on the 3 Tesla Siemens Trio scanner with a 32-channel head coil. Three acquisition protocols were part of the MRI session: 1) magnetization-prepared rapid acquisition gradient echo (MPRAGE) sequence with inplane resolution of 1 mm, slice thickness of 1.2 mm of total voxel number of 240x257x160 and TR, TE and TI were 2300, 2.98 and 900 ms respectively, 2) diffusion spectrum imaging (DSI) sequence with 128 diffusion-weighted images of b0 as a reference image and a maximum b-value of 8000 s/mm2. The time of acquisition was 13 min and 27s. The number of voxels was 96x96x34 with a resolution of 2.2x2.2x3.3 mm, and TR and TE were 6100 and 144 ms respectively. The issue of motion-artifacts linked to signal drop-outs was dealt with by visually inspecting the signal, and no subject had to be excluded as a result of this (17) .
Structural networks
Structural and diffusion MRI data were used to estimate the weighted and undirected structural connectivity matrices in the Connectome Mapping Toolkit (7, 18, 19) . Firstly, white matter, grey matter, and cerebrospinal fluid segmentation was performed on the structural data and further linearly registered to the b0 volumes of the DSI dataset. Secondly, the first three scales of the Lausanne multi-scale atlas were used to parcellate the grey matter. In detail, the first scale consisted of 68 cortical brain regions and 14 subcortical regions with scale two and three subdividing the first scale into 114 and 219 cortical regions (19) . Further, deterministic streamline tractography, estimating 32 diffusion directions per voxels, was used to reconstruct the structural connectivities from the DSI data (20) . The normalized connection density quantified the structural connectivity between brain regions and is defined as follows, where w represents an edge between brain regions i and j, S i and S j are the surface areas of regions i and j, f ∈ E f represents a streamline f in the set of streamlines E and (f ) is a length of a given streamline f (2, 7). The normalisation by brain region surfaces accounts for their slightly varying size and the streamline length normalisation accounts for a bias towards longer connections imposed by the tractography algorithm.
Functional Networks
Functional connectivity matrices were computed from fMRI BOLD time-series. Firstly, the first four-time points were excluded, yielding the number of time points to be T = 276 (21) . Rigid-body registration was applied to individual timeslices for motion-correction. The signal was then linearly detrended and corrected for physiological confounds and further motion artifacts by regressing white-matter, cerebrospinal fluid, and six motion (translations and rotations) signals. Lastly, the signal was spatially smoothed and bandpass-filtered between 0.01 − 0.1 Hz with Hamming windowed sinc FIR filter. Linear registration was performed between the average fMRI and MPRAGE images to obtain the ROIs timeseries (22) . An average timecourse for each brain region was computed for the three atlas scales. In order to obtain the functional matrices, the absolute value of the Pearson correlation was computed between individual brain regions' timecourses. All of the above was performed in subject native space with Connectome Mapper Toolkit and personalized Python and Matlab scripts(18)(23).
C Biomarker evaluation protocol
Our evaluation methodology is based on Abeel et al 2010 (24) used for biomarker identification in cancer diagnosis on microarray data. In order to assess the robustness of the biomarker selection process, we generate slight variations of the dataset and compare the outcome of selected features across these variations. Therefore, for a stable marker selection algorithm, small variations in the training set should not produce important changes in the retrieved set of features. Concretely, we generate 200 datasets from the original one, repeating 20 times 10-fold cross-validation (CV). Subsequently, for each CV partition, 90% of folds are used as a training set for selecting the model and features, and the remaining 10% as the testing set to provide an unbiased evaluation of a final model and assess the performance of the classifier. Therefore, the overall accuracy is given by the average testing accuracy across subsamplings. See Figure 1 for a schematic view of the methodology.
Assessing the stability of feature selection
We consider the vectorized connectivity matrices of the connectomes as input features for the biomarker selection process. Therefore, for a given connectome, one structural feature refers to the normalized connection density between two linked brain regions, whereas a functional feature refers to the Pearson correlation between two individual brain time courses.
We consider a dataset with M = 74 subjects and N features. If we denote the considered connectome resolution as d ∈ {83, 129, 234}, the number of features is N = d(d+1) 2 because of the symmetry of the connectivity matrices. Drawing k = 200 subsamplings and after applying a feature selection procedure (RFE-SVM) in the 90% of each subsampling, we obtain a respective feature signature, i.e. sequence of indices of selected features. Considering two signatures f i and f j obtained from different subsamplings i and j, the stability index (25) between f i and f j is defined as:
where r = |f i ∩ f j | and s = |f i | = |f j |, the size of the signature, is the number of selected features. This quantity measures the consistency between pairs of features. For s and N fixed KI increases when increases r, reaching its maximum at 1 when the two subsets are identical. The minimum value is bounded from below by −1 when the subsets are perfectly disjoint and the signature size of N/2. The overall stability index for a sequence of signatures is defined as the average of all pairwise stability indices on k subsamplings:
Given that I tot is bounded between −1 and 1, the greater this value the better the agreement between the selected subsets of features. In particular, a negative value for I tot indicates that the potential agreement between the selected biomarkers is mostly due to chance. In the sequel we will refer to the overall stability I tot as the Kuncheva index (25) .
D Measuring the classification performance
Because our dataset is class balanced and the task is a binary classification problem, we adopt the accuracy as the metric to quantify the performance of classification. This metric is defined as the ratio of correct classifications to the number of classifications done as follows:
where TP is true positive (number of control subjects classified correctly), TN is the true negative (patients classified correctly), FP is false positives (number of patients classified as control subjects) and FN is false negatives (number of control subjects misclassified).
E Embedded feature selection (RFE-SVM)
In this work we use a linear SVM classifier (10) . SVM has proven state of the art performance in computational biology (26) Another critical parameter is the regularization constant C of the SVM. The C parameter controls the misclassification rate of the classifier. A larger value makes the optimization choose a smaller margin hyperplane, losing generalization capabilities. The smaller the C, the larger the margin of separation, yielding more misclassified points. Therefore this parameter influences the classification accuracy of the model. We cross-validate the optimal C using only the training set, e.g., the 90% of each subsampling.
RESULTS

A Connectomes classification and features stability
First, we investigated the effect of different brain connectivity modalities and different scales in the discrimination of patients and normal controls. For each case, we control the step size and the percentage of selected features of the RFE-SVM algorithm, assessing their impact on the classification accuracy and the stability of the selected features. Figures 2, 3 and 4 show the average classification accuracy after performing RFE-SVM as well as the stability of selected biomarkers across modalities and scales. It can be seen that across scales, the functional connectivity matrices (Fig. 3 ) achieve better accuracies than the structural matrices (Fig. 2) , but conversely, structural matrices are more stable than functional. However, when combining the two modalities, i.e., by concatenating features of both modalities and letting the algorithm choose a blend of structural and functional features we achieve the best performances ( Fig. 4 ) in terms of both accuracy and stability. Note that the multi-modal curves overlap more than the structural and functional ones in the same resolutions. This shows that the multi-modal matrices provide similar performance in both accuracy and stability with respect to the number of dropped features in the RFE-SVM algorithm. It is to be noted that in the multi-modal case, the percentage of finally selected features is divided by two since we combine twice as many features as in the case of structural or functional connectivity alone. In doing so, the stopping criterion will be the same for all modalities. We observe in all cases that the stability increases with the percentage of selected features, which is expected since the overlapping be- tween signatures in Eq. 3 is more likely when more features are considered.
To further investigate the effect of modalities and resolutions on both classification accuracy and stability, we extract the best scores from Figs. 2, 3 and 4, and plot them in Fig. 5 . As demonstrated, the best trade-off between both metrics is achieved by 129 × 129 and 83 × 83 multi-modal resolutions.
The 234 × 234 multi-modal resolution has the lowest stability, which can be explained by the fact that finer resolutions are subsamplings of smaller ROIs introducing redundant and correlated edges in the connectome.
B Identification of brain regions in schizophrenia diagnosis
We proceed with the identification of brain areas involved in the classification of patients and controls. For simplicity in the identification of brain regions and comparison with other authors, we analyze the results for the multi-modal 83 × 83 connectome. Selected features in the graph space correspond to links representing either connection densities in the structural matrices or Pearson correlations in the functional connectome. Furthermore, inspecting the frequency of each selected feature across subsamplings informs us about the overall relevance of the edge in the classification. In other words, the frequency of an edge is indicative of the importance of the associated ROIs in the classification task. Given a brain connectivity matrix at a resolution r we define W as the r × r matrix where the element w i,j encodes the frequency at which the edge (i, j) is selected as relevant across subsamplings. Thus, the degree of relevance of an ROI i reads: Figure 7 represents the degree of relevance of brain regions for the multi-modal 83 × 83 connectome sorted in decreasing order. We defined the affected core (a-core) to be composed of brain areas with a degree of relevance higher than the overall average. These findings overlap with the brain regions in the definition of the affected core of Griffa et al. 2015 (7) . We plot the brain surface in Figure 9 , normalizing both FC and SC by the sum of all their connections and plotted the regions above the median distribution.
C Characterizing intergroup differences
We also investigate the influence of the selected biomarkers in the brain connectivity networks for patients and healthy subjects. To do so, the connectivity strength inside and outside the identified a-core was estimated and compared between both groups. The connectivity strength between ROIs was quantified with two metrics: the inverse apparent diffusion coefficient (iADC) and the generalized fractional anisotropy (gFA). These measures were weighted by the tract size expressed as the number of fibers. Subsequently, they were averaged over all connectivity strengths between a-core nodes and all connectivity strengths between regions outside the a-core. We reported the p−values from the Mann-Whitney-Wilcoxon (MWW) test for between-group differences of the averaged connectivity strengths, with a significance level α = 0.05.
As can be seen in Figure 6 , the weighted gFA and weighted iADC were altered in patients compared with controls. When averaging within the a-core the gFA was decreased with p−value = 0.00017 as well the iADC with p−value = 0.01845. None difference between groups was found in the outside a-core network of averaged gFA and iADC. Node strengths for multimodal 83x83 Fig. 9 . Brain surface representation of brain areas with higher relevance degree than the average for the 83 × 83 resolution of the multi-modal structural and functional mode.
iADC gFA Within a-core Outside a-core Fig. 6 . Boxplots of the distribution of connectivity strength averaged within (left) and outside the a-core. Both considered metrics, the generalized fractional anisotropy (gFA) and inverse apparent diffusion coefficient (ADC) were weighed by the size of the tracts.
CONCLUSIONS
This paper has investigated the effect of different connectivity modes of the human connectome in the identification of robust biomarkers for the diagnosis of schizophrenia. We perform an automatic feature selection process on the edge space aiming to retrieve a compact subset of meaningful biomarkers performing accurately on the diagnosis of schizophrenia. Besides, we analyze the robustness of the retrieved features concerning the sample variation, based on the fact that stable biomarkers will not change dramatically in different subsamplings of the underlying dataset (24) . It turns out that combining structural and functional connectivity matrices as a multi-modal representation of connectomes provides the best trade-off between high accurate and stable biomarkers. Importantly, the fact that the best accuracy and stability was achieved by combining SC and FC features reflects the relevance of both approaches to studying and classifying brain disorders. It contributes to the literature of the relationship between structural and functional large-scale networks (23, 27) and highlights the importance of understanding both approaches to explain complex neural disorders at least insofar the prediction of them is concerned. Based on the frequency from which the RFE-SVM algorithm selects relevant edges, we can map edges to the node space by looking at the strengths of connection densities or correlation between brain regions. The degree of relevance for nodes allows us to identify the affected core as the brain regions that are highly active during the training phase and therefore, are selected more often for relevant edges. Our findings overlap results from Griffa et al. 2015 (7) and provide further evidence of brain regions involved in the pathology. Furthermore, they offer a unique perspective in defining the affected core both from the influence of SC and FC and hence defining an SC-FC a-core which might give a richer description of the regions that are affected in SCHZ (6, 7) . The alterations of gFA and iADC values within and outside the a-core depicted in Fig. 6 , suggest a micro-structural impairment of the a-core regions given by an interruption of white matter across the affected core circuits.
